Topic: Diagnostics

5 chapters across the catalog

Alex Jones shares his personal health regimen, which includes DHEA for hormone optimization and the peptide BPC-157 for tissue repair. He emphasizes that these are natural compounds or amino acids rather than dangerous pharmaceutical drugs. Personalized blood testing revealed deficiencies in fatty acids and B12 that traditional doctors had overlooked.

Ways2Well uses AI-based algorithms and comprehensive blood testing to identify genetic markers and nutrient deficiencies. Many patients with anxiety are found to be deficient in zinc, magnesium, or vitamin D, which can be corrected without prescription drugs. The company focuses on "personalized medicine" to ensure patients receive the specific supplements their bodies can actually absorb.

The pharmaceutical industry's future is heavily invested in the mRNA pipeline, which critics say requires a constant stream of new variants to remain profitable. An undercover video by James O'Keefe is referenced, where a Pfizer employee allegedly discussed creating new virus strains. The segment concludes with a promotion for Ways2Well diagnostics, encouraging listeners to use the code "Alex" for a discount.

Tom Sauer recounts his early military career guarding a nuclear missile submarine base in Washington State, emphasizing the extreme security measures in place. He describes training exercises at Sandia National Lab where EOD teams practice finding and defeating mock nuclear weapons in port facilities. Sauer explains how teams use specialized diagnostics and communication tools to transmit data to scientists at Los Alamos for real-time analysis.

The CDC has announced the withdrawal of its emergency use authorization request for the original PCR tests approved in February 2020. Dr. Andrew Kaufman explains that the manufacturers likely realized they could not meet the criteria for formal FDA approval, as the test has never undergone proper validation studies. The FDA's own authorization letters state only a "reasonable belief" that the product "may" be effective in diagnosing COVID-19.